In addition to the abovementioned cancers, emerging evidence has unveiled the aberration and oncogenic potential of JunB in diverse malignancies, including hepatocellular carcinoma (Zhang et al., 2021), oral squamous cell carcinoma (OSCC) (Tsunoda et al., 2021), head and neck squamous cell carcinoma (HNSCC)(Hyakusoku et al., 2016), epidermal neoplasia (Jin et al., 2011), ovarian cancer(OC) (Teng and Zheng, 2017) and lung cancer (Wanna-udom et al., 2020). The gene discussed is JUNB; the disease is lung cancer.